FY21 appropriations

Dear Research Advocate, In their different ways, Super Tuesday and COVID-19 both speak to public sentiment. What are Americans’ expectations for those who represent them in Washington — and candidates who want to represent them in Washington — when it comes to promoting and protecting their best interests? A new Research!America-commissioned survey (in the field just days before COVID-19 captured worldwide public attention) found that Americans want their policymakers to consult with public health professionals and scientists; are deeply concerned about a diversity of public health issues affecting their families, their communities, and our nation as a whole; and believe there should be...
Dear Research Advocate, Super Tuesday is just days away. While media is largely focused on the Presidential candidates, candidates for Congress will also be selected. As we head into the general election, Research!America will be launching a non-partisan initiative to inform all candidates about where voters stand on medical and scientific research. Earlier this month, we released data from our January survey demonstrating widespread, bipartisan support for more research funding to address the many critical health issues facing Americans today. More poll data from our January survey will be online shortly; watch for it, and put it to use! We all think it’s important that candidates know...
Dear Research Advocate, The President released his proposed budget for FY21 earlier this week, kicking off the federal budget season. The President’s budget is a statement of priorities, even if it has no force of law (it’s the Congress that is charged in the Constitution with the ‘power of the purse’), and it rightly gets considerable attention. We think it’s deeply damaging for our nation that a higher priority isn’t being placed on science. Among the counterproductive proposals in the budget is a more than 7% cut to NIH and a double-digit cut to the CDC. Our colleague Jenny was quoted in Bloomberg Government as noting that, as underscored by the coronavirus outbreak, “the most important...
Dear Research Advocate, Last summer, the administration announced a new policy targeting fetal tissue research. The Washington Post reported this week on the troubling consequences for scientists, scientific progress, and thus patients. Research!America stood with patients and researchers against this retrograde policy change when it was first contemplated and, as part of a coalition led by the International Society for Stem Cell Research (ISCCR), we continue to push back. (It’s well to remember that fetal tissue research is not only playing a significant role today in research for vaccine development, Down syndrome, MS, and Parkinson’s, but its untapped potential holds significance for...

Pages

Sidebar Quote

Luck shouldn't play a role in why I'm alive.
Laurie MacCaskill, a seven-year pancreatic cancer survivor